CompletedNCT04347408
Seroprevalence of SARS-Cov-2 Antibodies in Children
Studying Multisystem inflammatory syndrome in children and adults
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Queen's University, Belfast
- Principal Investigator
- Thomas Waterfield, BMBChQueen's University, Belfast
- Intervention
- Covid-19 Antibody testing (IgG and IgM)(diagnostic_test)
- Enrollment
- 1100 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2020 – 2023
Study locations (5)
- Royal Belfast Hospital for Sick Children, Belfast, United Kingdom
- University Hospital of Wales, Cardiff, United Kingdom
- Royal Hospital for Children, Glasgow, United Kingdom
- Public Health England, London, United Kingdom
- Public Health England, Manchester, United Kingdom
Collaborators
Belfast Health and Social Care Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04347408 on ClinicalTrials.gov